Christopher DeRenzo, MD
Christopher DeRenzo, MD

Christopher DeRenzo, MD

Assistant Member, St. Jude Faculty



BA – Rutgers University, New Brunswick, New Jersey
MBA – Rutgers Business School, New Brunswick, New Jersey
MD – Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey
Residency – Case Western Reserve University, Rainbow Babies and Children’s Hospital, Cleveland, Ohio
Fellowship – Baylor College of Medicine, Texas Children’s Hospital, Houston, Texas

Research Interests

  • Adoptive cell therapy for pediatric patients with solid tumors
  • Enhancing CAR T cell function to overcome tumor-environment mediated immune suppression

Selected Publications

DeRenzo C, Krencuite G, Gottschalk S. The Landscape of CAR T Cells Beyond Acute Lymphoblastic Leukemia. American Society of Clinical Oncology Educational Book, 2018.

DeRenzo C, Gottschalk, S. Genetically modified T-cell therapy for the treatment of osteosarcoma: an update. J Clin Cell Immunol 7:417, 2016.

DeRenzo C, Gottschalk S. Genetically modified T-cell therapy for osteosarcoma. Advances in Experimental Medicine and Biology 804: 323-40, 2014.

Krebs S, Rodríguez-Cruz T, DeRenzo C, Gottschalk S. Genetically modified T cells to target glioblastoma. Frontiers in Oncology 3:322, 2013.

Lin S, Dolfi S, Amiri S, Li J, Budak-Alpdogan T, Lee K, DeRenzo C, Banerjee D, Glod J. P53 regulates the migration of mesenchymal stromal cells in response to the tumor microenvironment through both CXCL12-dependent and independent mechanisms. International Journal of Oncology 43(6):1817-23, 2013.

Tomie A, di Poce J, DeRenzo C, Pohorecky L. Autoshaping of ethanol drinking: an animal model of binge drinking. Alcohol and Alcoholism 37(2):138-46, 2002.

Last update: May 2018

For updates on COVID-19, please read.